| Product Code: ETC13245098 | Publication Date: Apr 2025 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
According to 6Wresearch internal database and industry insights, the Global Arthritis Market was valued at USD 64.1 Billion in 2024 and is expected to reach USD 89.5 Billion by 2031, growing at a compound annual growth rate of 7.33% during the forecast period (2025-2031).
The global arthritis market is characterized by a growing prevalence of arthritis across all age groups, with osteoarthritis and rheumatoid arthritis being the most common types. Factors such as the aging population, sedentary lifestyles, and obesity contribute to the increasing burden of arthritis worldwide. The market is driven by a range of treatment options including medications, physical therapy, and surgical interventions, with a growing emphasis on personalized medicine and biologic therapies. Key players in the market are investing in research and development to introduce innovative treatments and therapies, while advancements in technology such as telemedicine and wearable devices are shaping the future of arthritis management. Rising healthcare expenditure, increasing awareness about arthritis, and improving access to healthcare services in developing regions are expected to drive market growth in the coming years.
The Global Arthritis Market is experiencing a shift towards personalized medicine, with an increasing focus on developing targeted therapies based on genetic factors and specific disease mechanisms. Biologic drugs continue to dominate the market, offering effective treatment options with lower side effects compared to traditional medications. Emerging trends include the adoption of digital health technologies for remote monitoring of patients and data analytics for treatment optimization. The opportunities in the market lie in the growing aging population, rising prevalence of arthritis, and the increasing awareness about early diagnosis and treatment. Collaborations between pharmaceutical companies and research institutions for innovative drug development, as well as investments in novel therapies such as gene therapy and regenerative medicine, are key areas for potential growth in the Global Arthritis Market.
The Global Arthritis Market faces several challenges, including the high cost of treatment options, limited access to healthcare in developing countries, and the lack of curative therapies. The increasing prevalence of arthritis worldwide, particularly among the aging population, puts a strain on healthcare systems and resources. Additionally, the competitive landscape with multiple players offering similar products adds complexity to the market. The need for innovative and effective treatments, along with the growing demand for personalized medicine, further complicates the market dynamics. Regulatory hurdles, such as lengthy approval processes for new drugs, also contribute to the challenges faced by companies operating in the Global Arthritis Market. Overall, addressing these challenges requires collaboration among stakeholders to improve patient outcomes and drive market growth.
The global arthritis market is primarily driven by the increasing prevalence of arthritis worldwide, particularly among the aging population. As the elderly population grows, the demand for effective arthritis treatments and management options continues to rise. Technological advancements in the development of innovative therapies and the growing awareness about the importance of early diagnosis and treatment also contribute to market growth. Additionally, the rising healthcare expenditure, improving access to healthcare services, and the expanding research and development activities in the field of arthritis further propel market expansion. Furthermore, the increasing adoption of biologic drugs and personalized medicine approaches for arthritis treatment are expected to drive the market in the coming years.
Government policies related to the Global Arthritis Market vary by country but generally focus on increasing access to healthcare services, promoting research and development of innovative treatments, and implementing public health initiatives to raise awareness about arthritis prevention and management. Some countries have specific programs in place to provide financial assistance for arthritis patients, such as subsidies for medications or rehabilitation services. Additionally, regulatory bodies often play a role in ensuring the safety and efficacy of arthritis treatments through approval processes and monitoring post-market surveillance. Overall, government policies aim to address the growing burden of arthritis by supporting comprehensive care approaches and fostering collaborations between healthcare providers, researchers, and industry stakeholders to improve patient outcomes and quality of life.
The Global Arthritis Market is expected to witness steady growth in the coming years due to the increasing prevalence of arthritis worldwide, particularly among the aging population. Technological advancements in the development of innovative treatment options, such as biologics and personalized medicine, are likely to drive market expansion. Additionally, the rising awareness about early diagnosis and treatment of arthritis, coupled with favorable government initiatives for arthritis management, will further propel market growth. However, challenges such as high treatment costs and stringent regulatory requirements may hinder market progress. Overall, the Global Arthritis Market is poised for growth, with a focus on personalized, targeted therapies and a holistic approach to arthritis management expected to shape the market landscape in the future.
In the Global Arthritis Market, Asia is expected to witness significant growth due to the increasing geriatric population and rising prevalence of arthritis in countries like Japan, China, and India. North America is a key market player with a well-established healthcare infrastructure and high adoption of advanced treatment options. Europe also holds a considerable share in the market, driven by the presence of leading pharmaceutical companies and a growing focus on research and development in arthritis therapies. The Middle East and Africa region is anticipated to show moderate growth due to improving healthcare facilities and rising awareness about arthritis management. Latin America is experiencing a steady increase in arthritis cases, leading to a growing demand for effective treatment options and creating opportunities for market expansion in the region.
Global Arthritis Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Arthritis Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Arthritis Market Revenues & Volume, 2021 & 2031F |
3.3 Global Arthritis Market - Industry Life Cycle |
3.4 Global Arthritis Market - Porter's Five Forces |
3.5 Global Arthritis Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global Arthritis Market Revenues & Volume Share, By Rheumatoid Drug Type, 2021 & 2031F |
3.7 Global Arthritis Market Revenues & Volume Share, By Rheumatoid Treatment, 2021 & 2031F |
3.8 Global Arthritis Market Revenues & Volume Share, By Rheumatoid Diagnosis, 2021 & 2031F |
3.9 Global Arthritis Market Revenues & Volume Share, By Osteoarthritis Type, 2021 & 2031F |
3.10 Global Arthritis Market Revenues & Volume Share, By Osteoarthritis Diagnosis, 2021 & 2031F |
3.11 Global Arthritis Market Revenues & Volume Share, By Osteoarthritis Treatment, 2021 & 2031F |
3.12 Global Arthritis Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.13 Global Arthritis Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
4 Global Arthritis Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Arthritis Market Trends |
6 Global Arthritis Market, 2021 - 2031 |
6.1 Global Arthritis Market, Revenues & Volume, By Rheumatoid Drug Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global Arthritis Market, Revenues & Volume, By Biologics, 2021 - 2031 |
6.1.3 Global Arthritis Market, Revenues & Volume, By Non-Biologics, 2021 - 2031 |
6.1.4 Global Arthritis Market, Revenues & Volume, By Steroids, 2021 - 2031 |
6.1.5 Global Arthritis Market, Revenues & Volume, By Analgesics, 2021 - 2031 |
6.1.6 Global Arthritis Market, Revenues & Volume, By Glucocorticoids, 2021 - 2031 |
6.1.7 Global Arthritis Market, Revenues & Volume, By Others, 2021 - 2031 |
6.2 Global Arthritis Market, Revenues & Volume, By Rheumatoid Treatment, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global Arthritis Market, Revenues & Volume, By Synovectomy, 2021 - 2031 |
6.2.3 Global Arthritis Market, Revenues & Volume, By Tendon Repair, 2021 - 2031 |
6.2.4 Global Arthritis Market, Revenues & Volume, By Joint Fusion, 2021 - 2031 |
6.2.5 Global Arthritis Market, Revenues & Volume, By Symptomatic Treatment, 2021 - 2031 |
6.2.6 Global Arthritis Market, Revenues & Volume, By Intermediate Corticosteroid Therapies, 2021 - 2031 |
6.2.7 Global Arthritis Market, Revenues & Volume, By DMARD Therapies, 2021 - 2031 |
6.3 Global Arthritis Market, Revenues & Volume, By Rheumatoid Diagnosis, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Global Arthritis Market, Revenues & Volume, By C.R.P. Test, 2021 - 2031 |
6.3.3 Global Arthritis Market, Revenues & Volume, By C.C.P., 2021 - 2031 |
6.3.4 Global Arthritis Market, Revenues & Volume, By E.S.R. Test, 2021 - 2031 |
6.4 Global Arthritis Market, Revenues & Volume, By Osteoarthritis Type, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Global Arthritis Market, Revenues & Volume, By Hip, 2021 - 2031 |
6.4.3 Global Arthritis Market, Revenues & Volume, By Spinal, 2021 - 2031 |
6.4.4 Global Arthritis Market, Revenues & Volume, By Knee, 2021 - 2031 |
6.4.5 Global Arthritis Market, Revenues & Volume, By Foot and Ankle, 2021 - 2031 |
6.4.6 Global Arthritis Market, Revenues & Volume, By Shoulder, 2021 - 2031 |
6.4.7 Global Arthritis Market, Revenues & Volume, By Hand, 2021 - 2031 |
6.5 Global Arthritis Market, Revenues & Volume, By Osteoarthritis Diagnosis, 2021 - 2031 |
6.5.1 Overview & Analysis |
6.5.2 Global Arthritis Market, Revenues & Volume, By Imaging, 2021 - 2031 |
6.5.3 Global Arthritis Market, Revenues & Volume, By Joint Fluid Analysis, 2021 - 2031 |
6.5.4 Global Arthritis Market, Revenues & Volume, By Others, 2021 - 2031 |
6.6 Global Arthritis Market, Revenues & Volume, By Osteoarthritis Treatment, 2021 - 2031 |
6.6.1 Overview & Analysis |
6.6.2 Global Arthritis Market, Revenues & Volume, By Medication, 2021 - 2031 |
6.6.3 Global Arthritis Market, Revenues & Volume, By Drugs, 2021 - 2031 |
6.6.4 Global Arthritis Market, Revenues & Volume, By Assistive Devices, 2021 - 2031 |
6.6.5 Global Arthritis Market, Revenues & Volume, By Surgery, 2021 - 2031 |
6.6.6 Global Arthritis Market, Revenues & Volume, By Therapy, 2021 - 2031 |
6.7 Global Arthritis Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
6.7.1 Overview & Analysis |
6.7.2 Global Arthritis Market, Revenues & Volume, By Oral, 2021 - 2031 |
6.7.3 Global Arthritis Market, Revenues & Volume, By Parenteral, 2021 - 2031 |
6.8 Global Arthritis Market, Revenues & Volume, By End-Users, 2021 - 2031 |
6.8.1 Overview & Analysis |
6.8.2 Global Arthritis Market, Revenues & Volume, By Hospitals, 2021 - 2031 |
6.8.3 Global Arthritis Market, Revenues & Volume, By Specialty Clinics, 2021 - 2031 |
6.8.4 Global Arthritis Market, Revenues & Volume, By Household, 2021 - 2031 |
6.8.5 Global Arthritis Market, Revenues & Volume, By Medical Institutes, 2021 - 2031 |
6.8.6 Global Arthritis Market, Revenues & Volume, By Research Organizations, 2021 - 2031 |
6.8.7 Global Arthritis Market, Revenues & Volume, By Others, 2021 - 2031 |
7 North America Arthritis Market, Overview & Analysis |
7.1 North America Arthritis Market Revenues & Volume, 2021 - 2031 |
7.2 North America Arthritis Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) Arthritis Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada Arthritis Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America Arthritis Market, Revenues & Volume, 2021 - 2031 |
7.3 North America Arthritis Market, Revenues & Volume, By Rheumatoid Drug Type, 2021 - 2031 |
7.4 North America Arthritis Market, Revenues & Volume, By Rheumatoid Treatment, 2021 - 2031 |
7.5 North America Arthritis Market, Revenues & Volume, By Rheumatoid Diagnosis, 2021 - 2031 |
7.6 North America Arthritis Market, Revenues & Volume, By Osteoarthritis Type, 2021 - 2031 |
7.7 North America Arthritis Market, Revenues & Volume, By Osteoarthritis Diagnosis, 2021 - 2031 |
7.8 North America Arthritis Market, Revenues & Volume, By Osteoarthritis Treatment, 2021 - 2031 |
7.9 North America Arthritis Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.10 North America Arthritis Market, Revenues & Volume, By End-Users, 2021 - 2031 |
8 Latin America (LATAM) Arthritis Market, Overview & Analysis |
8.1 Latin America (LATAM) Arthritis Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) Arthritis Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil Arthritis Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico Arthritis Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina Arthritis Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM Arthritis Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) Arthritis Market, Revenues & Volume, By Rheumatoid Drug Type, 2021 - 2031 |
8.4 Latin America (LATAM) Arthritis Market, Revenues & Volume, By Rheumatoid Treatment, 2021 - 2031 |
8.5 Latin America (LATAM) Arthritis Market, Revenues & Volume, By Rheumatoid Diagnosis, 2021 - 2031 |
8.6 Latin America (LATAM) Arthritis Market, Revenues & Volume, By Osteoarthritis Type, 2021 - 2031 |
8.7 Latin America (LATAM) Arthritis Market, Revenues & Volume, By Osteoarthritis Diagnosis, 2021 - 2031 |
8.8 Latin America (LATAM) Arthritis Market, Revenues & Volume, By Osteoarthritis Treatment, 2021 - 2031 |
8.9 Latin America (LATAM) Arthritis Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
8.10 Latin America (LATAM) Arthritis Market, Revenues & Volume, By End-Users, 2021 - 2031 |
9 Asia Arthritis Market, Overview & Analysis |
9.1 Asia Arthritis Market Revenues & Volume, 2021 - 2031 |
9.2 Asia Arthritis Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India Arthritis Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China Arthritis Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan Arthritis Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia Arthritis Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia Arthritis Market, Revenues & Volume, By Rheumatoid Drug Type, 2021 - 2031 |
9.4 Asia Arthritis Market, Revenues & Volume, By Rheumatoid Treatment, 2021 - 2031 |
9.5 Asia Arthritis Market, Revenues & Volume, By Rheumatoid Diagnosis, 2021 - 2031 |
9.6 Asia Arthritis Market, Revenues & Volume, By Osteoarthritis Type, 2021 - 2031 |
9.7 Asia Arthritis Market, Revenues & Volume, By Osteoarthritis Diagnosis, 2021 - 2031 |
9.8 Asia Arthritis Market, Revenues & Volume, By Osteoarthritis Treatment, 2021 - 2031 |
9.9 Asia Arthritis Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
9.10 Asia Arthritis Market, Revenues & Volume, By End-Users, 2021 - 2031 |
10 Africa Arthritis Market, Overview & Analysis |
10.1 Africa Arthritis Market Revenues & Volume, 2021 - 2031 |
10.2 Africa Arthritis Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa Arthritis Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt Arthritis Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria Arthritis Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa Arthritis Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa Arthritis Market, Revenues & Volume, By Rheumatoid Drug Type, 2021 - 2031 |
10.4 Africa Arthritis Market, Revenues & Volume, By Rheumatoid Treatment, 2021 - 2031 |
10.5 Africa Arthritis Market, Revenues & Volume, By Rheumatoid Diagnosis, 2021 - 2031 |
10.6 Africa Arthritis Market, Revenues & Volume, By Osteoarthritis Type, 2021 - 2031 |
10.7 Africa Arthritis Market, Revenues & Volume, By Osteoarthritis Diagnosis, 2021 - 2031 |
10.8 Africa Arthritis Market, Revenues & Volume, By Osteoarthritis Treatment, 2021 - 2031 |
10.9 Africa Arthritis Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
10.10 Africa Arthritis Market, Revenues & Volume, By End-Users, 2021 - 2031 |
11 Europe Arthritis Market, Overview & Analysis |
11.1 Europe Arthritis Market Revenues & Volume, 2021 - 2031 |
11.2 Europe Arthritis Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom Arthritis Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany Arthritis Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France Arthritis Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe Arthritis Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe Arthritis Market, Revenues & Volume, By Rheumatoid Drug Type, 2021 - 2031 |
11.4 Europe Arthritis Market, Revenues & Volume, By Rheumatoid Treatment, 2021 - 2031 |
11.5 Europe Arthritis Market, Revenues & Volume, By Rheumatoid Diagnosis, 2021 - 2031 |
11.6 Europe Arthritis Market, Revenues & Volume, By Osteoarthritis Type, 2021 - 2031 |
11.7 Europe Arthritis Market, Revenues & Volume, By Osteoarthritis Diagnosis, 2021 - 2031 |
11.8 Europe Arthritis Market, Revenues & Volume, By Osteoarthritis Treatment, 2021 - 2031 |
11.9 Europe Arthritis Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
11.10 Europe Arthritis Market, Revenues & Volume, By End-Users, 2021 - 2031 |
12 Middle East Arthritis Market, Overview & Analysis |
12.1 Middle East Arthritis Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East Arthritis Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia Arthritis Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE Arthritis Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey Arthritis Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East Arthritis Market, Revenues & Volume, By Rheumatoid Drug Type, 2021 - 2031 |
12.4 Middle East Arthritis Market, Revenues & Volume, By Rheumatoid Treatment, 2021 - 2031 |
12.5 Middle East Arthritis Market, Revenues & Volume, By Rheumatoid Diagnosis, 2021 - 2031 |
12.6 Middle East Arthritis Market, Revenues & Volume, By Osteoarthritis Type, 2021 - 2031 |
12.7 Middle East Arthritis Market, Revenues & Volume, By Osteoarthritis Diagnosis, 2021 - 2031 |
12.8 Middle East Arthritis Market, Revenues & Volume, By Osteoarthritis Treatment, 2021 - 2031 |
12.9 Middle East Arthritis Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
12.10 Middle East Arthritis Market, Revenues & Volume, By End-Users, 2021 - 2031 |
13 Global Arthritis Market Key Performance Indicators |
14 Global Arthritis Market - Export/Import By Countries Assessment |
15 Global Arthritis Market - Opportunity Assessment |
15.1 Global Arthritis Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global Arthritis Market Opportunity Assessment, By Rheumatoid Drug Type, 2021 & 2031F |
15.3 Global Arthritis Market Opportunity Assessment, By Rheumatoid Treatment, 2021 & 2031F |
15.4 Global Arthritis Market Opportunity Assessment, By Rheumatoid Diagnosis, 2021 & 2031F |
15.5 Global Arthritis Market Opportunity Assessment, By Osteoarthritis Type, 2021 & 2031F |
15.6 Global Arthritis Market Opportunity Assessment, By Osteoarthritis Diagnosis, 2021 & 2031F |
15.7 Global Arthritis Market Opportunity Assessment, By Osteoarthritis Treatment, 2021 & 2031F |
15.8 Global Arthritis Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
15.9 Global Arthritis Market Opportunity Assessment, By End-Users, 2021 & 2031F |
16 Global Arthritis Market - Competitive Landscape |
16.1 Global Arthritis Market Revenue Share, By Companies, 2024 |
16.2 Global Arthritis Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here